心脏代谢疾病市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00025374
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 293
Buy Now

心脏代谢疾病市场预计将从 2021 年的 934.9441 亿美元增至 2028 年的 1218.0449 亿美元;预计 2021 年至 2028 年复合年增长率为 3.9%。

心脏代谢疾病的特点是一组异常和症状,这些异常和症状会增加个体患心脏病的风险心血管疾病。高血压、肥胖、胰岛素抵抗、血脂异常、胆固醇水平(LDL)不良和葡萄糖耐量是心脏代谢疾病的一些症状。患有心脏代谢综合征的人容易患上许多其他危及生命的疾病,例如 2 型糖尿病、中风、冠状动脉疾病 (CAD) 和心血管疾病 (CVD)。遗传和环境条件都是疾病发生的原因。

战略见解

心脏代谢疾病市场的增长主要归因于以下因素随着心脏代谢疾病患病率的增加和 CMD 疗法的创新。然而,低收入和中等收入国家 (LMIC) 对 CVD 的诊断不足正在阻碍市场的增长。

心血管代谢疾病市场的利润丰厚的区域


< /h3>

市场洞察
心脏代谢疾病的患病率不断增加

心脏代谢疾病 (CMD) 是全球主要死亡原因之一。这些疾病主要是由不健康的生活方式、缺乏运动、吸烟和不健康的饮食引起的。 CMD 包括心血管疾病 (CVD)、糖尿病和慢性肾功能衰竭。根据世界卫生组织的数据,2019 年约有 1790 万人死于心血管疾病,占全球死亡人数的 32%。在这些死亡中,85% 是由于心脏病发作和中风。

大多数心血管疾病可以通过解决行为风险因素来预防,例如烟草摄入、不健康的饮食选择、肥胖、缺乏身体活动和饮酒量。糖尿病是危及生命的慢性疾病之一,尚无功能性治愈方法。它会导致各种并发症并增加过早死亡的总体风险。心脏病、中风、肾衰竭、截肢、视力丧失和神经损伤是与糖尿病相关的主要并发症。根据国际糖尿病联盟 (IDF) 的数据,2019 年,约有 4.63 亿成年人患有糖尿病,预计到 2045 年这一数字将达到 7 亿。

由于吸烟、缺乏运动、饮酒和不健康的饮食习惯的增加,全球患有一种或多种 CMD 的人数增加。根据世界卫生组织 2021 年 7 月的统计数据,每年有超过 800 万人因烟草消费而死亡。低收入和中等收入国家的消费量较高,全球80%的消费群居住在这些国家。肥胖症患病率的增加也导致了患有 CMD 的患者群体的增加。随着 CMD 患病率的迅速上升,对适当的心脏代谢疾病治疗的需求猛增,从而导致市场的巨大增长。

基于类型的见解

心脏代谢疾病市场按类型分为心血管疾病 (CVD)、高血压、2 型糖尿病和肥胖症。心血管疾病 (CVD) 细分市场在 2021 年占据最大市场份额,预计该细分市场在预测期内的复合年增长率最高。

心脏代谢疾病市场(按类型) 2021 年和 2028 年


基于治疗的见解

按治疗方法,心脏代谢疾病市场分为 ACE 抑制剂、利尿剂、格华止等。 ACE 抑制剂细分市场在 2021 年占据最大市场份额,预计该细分市场在预测期内的复合年增长率最高。

基于剂量的见解

心脏代谢疾病市场按剂量分为片剂和注射剂。平板电脑细分市场将在 2021 年占据更大的市场份额,预计在预测期内市场复合年增长率将更高。

基于管理的洞察路线

基于管理的洞察路线

h3>

心脏代谢疾病市场按给药途径分为口服和静脉注射。 2021年,口腔细分市场将占据更大的市场份额,预计未来几年的复合年增长率将更高。

基于最终用户的洞察

心脏代谢疾病市场按最终用户划分为诊所、医院和家庭护理环境。 2021年,医院细分市场占据最大市场份额,预计在预测期内复合年增长率最高。


产品上市和批准是普遍采用的策略公司扩大其全球足迹和产品组合。此外,实验室开发的测试市场参与者专注于扩大客户群的合作伙伴战略,这反过来又使他们能够在全球范围内保持自己的品牌声誉。

报告将心脏代谢疾病市场细分如下

根据类型,心脏代谢疾病市场分为心血管疾病(CVD)、高血压、2型糖尿病和肥胖。根据治疗方法,市场分为 ACE 抑制剂、利尿剂、格华止等。根据剂量,心脏代谢疾病市场分为片剂和注射剂。根据给药途径,市场分为口服和静脉注射。根据最终用户,心脏代谢疾病市场分为诊所、医院和家庭护理环境。按地理位置划分,市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚) 、韩国以及亚太其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷和南美洲和中美洲其他地区)。

公司简介

  • 礼来公司< /li>
  • 拜耳公司
  • Arrowhead Pharmaceuticals, Inc
  • 诺华公司
  • 勃林格殷格翰国际有限公司
  • 诺和诺德 A/ S
  • 阿斯利康
  • Alnylam Pharmaceuticals, Inc.
  • Cardax, Inc
  • Kowa Company, Ltd.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is cardiometabolic diseases market?

Cardiometabolic disease is characterized by a group of abnormalities and symptoms that raise the risk of individuals developing cardiovascular disease. Hypertension, obesity, insulin resistance, dyslipidemia, poor cholesterol profile (LDL), and glucose tolerance are a few symptoms of cardiometabolic diseases. Individuals suffering from cardiometabolic syndrome are prone to many other life-threatening diseases, such as type 2 diabetes, stroke, coronary artery disease (CAD), and cardiovascular disease (CVD). Both genetic and environmental conditions are responsible for the development of the diseases.

What are the driving factors for the cardiometabolic diseases market across the country?

The factors that are driving and restraining factors that will affect cardiometabolic diseases market in the coming years. Factors such as increasing prevalence of cardiometabolic diseases and innovation in CMDs therapeutics. However, underdiagnosis of CVDs in low- and middle-income countries (LMICs) is hampering the growth of the market.

Who are the major players in the cardiometabolic diseases market?

The cardiometabolic diseases market majorly consists of the players such as as Eli Lilly and Company; Bayer AG; Arrowhead Pharmaceuticals, Inc; Novartis AG; Boehringer Ingelheim International GmbH; Novo Nordisk A/S; AstraZeneca; Alnylam Pharmaceuticals, Inc.; Cardax, Inc.; and Kowa Company, Ltd among others.

Which segment is dominating the cardiometabolic diseases market?

The global cardiometabolic diseases market cardiovascular disease (CVD), hypertension, type 2 diabetes, and obesity. The cardiovascular disease (CVD) segment is expected to hold the largest share and register the highest CAGR in the market during the forecast period.

The List of Companies - Cardiometabolic Diseases Market

  1. Eli Lilly and Company
  2. Bayer AG
  3. Arrowhead Pharmaceuticals, Inc
  4. Novartis AG
  5. Boehringer Ingelheim International GmbH
  6. Novo Nordisk A/S
  7. AstraZeneca
  8. Alnylam Pharmaceuticals, Inc.
  9. Cardax, Inc
  10. Kowa Company, Ltd.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports